Attention-Deficit Hyperactivity Disorder Clinical Trial
Official title:
Johnston County ADHD Study: Environmental, Reproductive and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)
Verified date | May 24, 2007 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
We propose a population-based case-control study among 7000 elementary school children in semi-rural Johnston County, NC. Teachers will complete a screening form on each child. Controls will be randomly selected. Mothers of potential cases and controls will be interviewed by telephone about their child's symptoms of ADHD and exposure history, their family history of ADHD, and their reproductive and exposure history. Children's shed baby teeth will be analyzed for lead. Mothers will complete brief parenting scales and the Child Behavior Checklist. School records will be collected. The study goals are to identify risk factors for ADHD including preterm delivery and childhood lead exposure.
Status | Completed |
Enrollment | 8000 |
Est. completion date | May 24, 2007 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 8 Years and older |
Eligibility |
- INCLUSION CRITERIA: During the first phase of the study, all children will be screened by the homeroom teacher, EXCEPT for those students in certain self-contained classrooms. Self-contained classrooms for students with an IQ less than 70 or autism will be omitted from the screening. In the second phase of the study, children designated as "LEP", or Low English Proficiency, will be excluded from the study. |
Country | Name | City | State |
---|---|---|---|
United States | NIEHS, Research Triangle Park | Research Triangle Park | North Carolina |
Lead Sponsor | Collaborator |
---|---|
National Institute of Environmental Health Sciences (NIEHS) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02827188 -
Cognitive Restructuring in ADHD: Functional Training
|
N/A | |
Recruiting |
NCT05374187 -
Efficacy of Trigeminal Nerve Stimulation for ADHD
|
N/A | |
Enrolling by invitation |
NCT04229251 -
Online Mindfulness-Based Intervention for ADHD
|
N/A | |
Completed |
NCT04416360 -
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak
|
N/A | |
Recruiting |
NCT01657721 -
Working Memory Training in ADHD (The Engage Study)
|
Phase 1 | |
Completed |
NCT04786730 -
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT01323192 -
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
|
Phase 3 | |
Recruiting |
NCT05165511 -
Families, Responsibility, Education, Support, and Health for Executive Function
|
N/A | |
Completed |
NCT01886469 -
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1/Phase 2 | |
Completed |
NCT01010750 -
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1 | |
Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
Completed |
NCT01624649 -
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
|
Phase 4 | |
Completed |
NCT03806946 -
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
|
||
Recruiting |
NCT05869253 -
The Efficacy of Equine Assisted Occupational Therapy, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
|
N/A | |
Completed |
NCT01907360 -
Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
|
Phase 1/Phase 2 |